Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > About Us > Corporate Governance > Board Committees & Charters > Audit Committee Financial Expertise > Audit Committee Financial Expertise

Audit Committee Financial Expertise

The Pfizer Board: Audit Committee Financial Expertise

The Pfizer Board of Directors has determined that all the members of the Audit Committee meet the financial literacy requirements of the New York Stock Exchange Listed Company rules relating to audit committees and that and that the following members of the Committee — Mr. Cornwell, Mr. Burns, Ms. Nora Johnson and Mr. Sanger — are "audit committee financial experts" for purposes of the SEC's rules.

The Board of Directors also has determined that each of the members of the Audit Committee is "independent," as defined by the rules of the New York Stock Exchange.

Board Member Independent Position
Dennis A. Ausiello Yes Member
M. Anthony Burns Yes Member
W. Don Cornwell Yes Chair
Suzanne Nora Johnson Yes Member
Stephen W. Sanger Yes Member
Printable Version
 
 

Pfizer Annual Report

Pfizer Annual Report

Gain insight into Pfizer's ownership culture and achievements.

  • View the Interactive 2012 Pfizer Annual Review

Source URL: http://www.pfizer.com/about/corporate_governance/audit_committee_financial_experts